Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort versus Zenhale in step III-IV asthma
IRCT20150107020592N17Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of budesonide and mometasone in asthma (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: FEV1, Duration of hospitalization and 1 more. Started Aug 2017; status: completed.
02
Drugs
budesonidemometasone
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20150107020592N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150107020592N17.